Edition:
India

Becton Dickinson and Co (BDX.N)

BDX.N on New York Stock Exchange

233.97USD
21 May 2019
Change (% chg)

$4.61 (+2.01%)
Prev Close
$229.36
Open
$230.54
Day's High
$235.22
Day's Low
$230.54
Volume
374,265
Avg. Vol
282,127
52-wk High
$265.87
52-wk Low
$208.67

Latest Key Developments (Source: Significant Developments)

BD Gets FDA Approval For First Venous Stent
Thursday, 14 Mar 2019 

March 14 (Reuters) - Becton Dickinson and Co ::BD RECEIVES U.S. FDA APPROVAL FOR FIRST VENOUS STENT TO TREAT ILIOFEMORAL VENOUS OCCLUSIVE DISEASE.BECTON DICKINSON AND CO - VENOVO VENOUS STENT PROVEN SAFE AND EFFECTIVE IN ILIAC AND FEMORAL VEINS.  Full Article

UK Regulator Says No Safety Concerns On Recall Of C.R. Bard's Urogynaecological Mesh
Thursday, 7 Mar 2019 

March 7 (Reuters) - UK's Medicines And Healthcare Products Regulatory Agency: :UK'S MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY - MEDICAL DEVICE ALERT ISSUED FOR UROGYNAECOLOGICAL MESH MANUFACTURED BY C.R. BARD.UK'S MEDICINES & HEALTHCARE PRODUCTS REGULATORY AGENCY - ALERT ISSUED ON C.R. BARD REMOVING VAGINAL MESH FOR SUI, PELVIC ORGAN PROLAPSE FROM MARKET.UK'S MEDICINES & HEALTHCARE PRODUCTS REGULATORY AGENCY - NO SPECIFIC SAFETY CONCERNS ASSOCIATED WITH RECALL OF C.R. BARD'S UROGYNAECOLOGICAL MESH.  Full Article

Becton Dickinson and Co Sees Q1 EPS Of $2.05
Thursday, 17 Jan 2019 

Jan 17 (Reuters) - Becton Dickinson and Co ::BD ANNOUNCES PRELIMINARY RESULTS FOR 2019 FIRST FISCAL QUARTER; REAFFIRMS FISCAL 2019 GUIDANCE.SEES Q1 EARNINGS PER SHARE ABOUT $2.05.Q1 PRELIMINARY EARNINGS PER SHARE $2.05.Q1 EARNINGS PER SHARE ESTIMATE $2.61 -- REFINITIV IBES DATA.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $12.05 TO $12.15.Q1 PRELIMINARY ADJUSTED EARNINGS PER SHARE $2.70.SEES FY 2019 REVENUE UP 8.5 TO 9.5 PERCENT.Q1 REVENUE $4.16 BILLION VERSUS REFINITIV IBES ESTIMATE OF $4.11 BILLION.SEES Q1 2019 REVENUE $4.16 BILLION.REAFFIRMS PREVIOUSLY ISSUED FISCAL YEAR 2019 REVENUE AND ADJUSTED DILUTED EPS GUIDANCE.Q1 EARNINGS PER SHARE VIEW $2.61, REVENUE VIEW $4.11 BILLION -- REFINITIV IBES DATA.FY2019 EARNINGS PER SHARE VIEW $12.12, REVENUE VIEW $17.43 BILLION -- REFINITIV IBES DATA.  Full Article

Becton, Dickinson And Co Sets Quarterly Dividend Of $0.77 Per Share
Tuesday, 20 Nov 2018 

Nov 19 (Reuters) - Becton Dickinson and Co ::SETS QUARTERLY DIVIDEND OF $0.77PER SHARE.SAYS DIVIDEND REPRESENTS INCREASE OF 2.7 PERCENT FROM PREVIOUS QUARTER.  Full Article

Becton Dickinson Announces Clinical Trial Data For The Lutonix 014 DCB
Wednesday, 7 Nov 2018 

Nov 7 (Reuters) - Becton Dickinson and Co ::BD ANNOUNCES CLINICAL TRIAL DATA FOR THE LUTONIX® 014 DRUG-COATED BALLOON BELOW-THE-KNEE IDE TRIAL.BECTON DICKINSON - STUDY'S PRIMARY SAFETY ENDPOINT WAS MET SHOWING STATISTICALLY SIGNIFICANT SAFETY EQUIVALENCE BETWEEN LUTONIX 014 DCB & STANDARD PTA CATHETER.  Full Article

Becton Dickinson Says Entered 364-Day Term Loan Agreement
Friday, 14 Sep 2018 

Sept 13 (Reuters) - Becton Dickinson and Co ::BECTON DICKINSON AND CO SAYS ON SEPTEMBER 6, CO ENTERED 364-DAY TERM LOAN AGREEMENT - SEC FILING.BECTON DICKINSON AND CO - TERM LOAN AGREEMENT IS A SENIOR UNSECURED TERM LOAN FACILITY THAT PROVIDED CO WITH $750 MILLION OF TERM LOANS.BECTON DICKINSON AND CO - BORROWINGS UNDER TERM LOAN FACILITY WERE USED TO PARTIALLY REFINANCE 3 YEAR TERM LOAN AGREEMENT, DATED AS OF MAY 12, 2017.  Full Article

BD Statement On Divestiture Of Advanced Bioprocessing Business
Friday, 7 Sep 2018 

Sept 7 (Reuters) - Becton Dickinson and Co ::BD STATEMENT ON DIVESTITURE OF ADVANCED BIOPROCESSING BUSINESS.BECTON DICKINSON AND CO - EXPECTS TO RECORD A TAX GAIN ON TRANSACTION AT TIME OF CLOSING.BECTON DICKINSON - FOR FISCAL 2018, BD ESTIMATES CONTRIBUTION FROM ADVANCED BIOPROCESSING BUSINESS TO EPS OF ABOUT $0.13 TO $0.15 ON A FY BASIS.  Full Article

Thermo Fisher Scientific To Acquire Advanced Bioprocessing Business From BD
Friday, 7 Sep 2018 

Sept 7 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC TO ACQUIRE ADVANCED BIOPROCESSING BUSINESS FROM BD.THERMO FISHER SCIENTIFIC INC - BD'S ADVANCED BIOPROCESSING BUSINESS WILL BE INTEGRATED INTO THERMO FISHER'S LIFE SCIENCES SOLUTIONS SEGMENT.  Full Article

Becton Dickinson and Co Posts Q3 Adj Earnings $2.91/Shr
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - Becton Dickinson and Co ::BD ANNOUNCES RESULTS FOR 2018 THIRD FISCAL QUARTER; RAISES FISCAL 2018 REVENUE GUIDANCE.Q3 EARNINGS PER SHARE $2.03.Q3 REVENUE $4.278 BILLION VERSUS I/B/E/S VIEW $4.24 BILLION.Q3 EARNINGS PER SHARE VIEW $2.86 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $10.95 TO $11.05.Q3 ADJUSTED EARNINGS PER SHARE $2.91.RAISING FULL FISCAL YEAR 2018 REVENUE GUIDANCE, EXPECTS GROWTH TO EXCEED 31.5 PERCENT ON A REPORTED BASIS.BECTON DICKINSON - FOR FY18, ON A COMPARABLE, CURRENCY-NEUTRAL BASIS, CO IS ALSO RAISING ITS REVENUE GUIDANCE, NOW EXPECTS GROWTH TO EXCEED 5.5 PERCENT.REAFFIRMS ACQUISITION OF C.R. BARD EXPECTED TO BE ACCRETIVE TO ADJUSTED. EARNINGS PER SHARE ON A HIGH-SINGLE DIGIT BASIS IN FISCAL 2019.  Full Article

Becton Dickinson Files For Potential Mixed Shelf Offering
Friday, 27 Apr 2018 

April 26 (Reuters) - Becton Dickinson and Co ::BECTON DICKINSON AND CO FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED- SEC FILING.  Full Article